Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,042.00
Bid: 9,088.00
Ask: 9,092.00
Change: -78.00 (-0.86%)
Spread: 4.00 (0.044%)
Open: 9,152.00
High: 9,210.00
Low: 9,042.00
Prev. Close: 9,120.00
NXT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

5 May 2022 07:00

RNS Number : 3726K
Next PLC
05 May 2022
 

Date:

Embargoed until 07:00 hrs, Thursday 5 May 2022

Contacts:

Amanda James, Group Finance Director (analyst calls)

Tel: 0333 777 8888

 

Alistair Mackinnon-Musson, Rowbell PR

Tel: 020 7717 5239

Photographs:

https://www.nextplc.co.uk/media/image-gallery/campaign-images

 

NEXT PLC

Trading Statement - 5 May 2022

HEADLINES

In the thirteen weeks to 30 April full price sales1 were up +21.3% versus last year, in line with our guidance for this period.

We are maintaining our guidance for full year profit before tax at £850m, which would be up +3.3% versus last year. Guidance for Earnings Per Share of 557.3p would be up +5.0% versus last year. 

1 Full price sales are total sales excluding VAT, less items sold in our mid-season and end-of-season Sales events, our Clearance operations and sales through Total Platform. These are not statutory sales.

FULL PRICE SALES PERFORMANCE BY BUSINESS CHANNEL

Full price sales versus last year are set out below. Last year, most of our Retail stores were shut for the majority of the first quarter, which is why Retail growth is so strong at +285%. Conversely, last year Online sales were boosted by Retail closures, which is why we planned Online sales to be down in the first quarter against last year. Online sales against three years ago remained strong and were up +47% versus 2019/20.

The right hand column shows the three year growth versus 2019/20, which is the most recent year not disrupted by COVID. The three year growth of +19.5% is the equivalent of a compound annual growth rate (CAGR) of +6.1%. 

Full price sales (VAT exclusive) by division

13 weeks to 30 April

One year growth

2022/23 vs 2021/22

 

13 weeks to 30 April

Three year growth

2022/23 vs 2019/20

 

Online NEXT UK

- 24%

 

+23%

Online LABEL UK

+20%

 

+106%

Total Online UK

- 11%

 

+47%

Online Overseas2

- 12%

 

+47%

Total Online

- 11%

 

+47%

Retail (UK and Ireland)

+285%

 

- 8%

Total Product full price sales

+22%

 

+21%

Finance interest income

+11%

 

- 2%

Total full price sales including interest income

+21.3%

 

+19.5%

2 In March, we closed our websites in Ukraine and Russia. Excluding Ukraine and Russia, Overseas full price sales were down -7% versus last year and up +60% versus three years ago.

 

GUIDANCE FOR FULL PRICE SALES, PROFIT AND EARNINGS PER SHARE

Our guidance for the full year is set out below. The guidance for sales and profit before tax remains unchanged from that given in our Year End Results in March. 

Guidance for 2022/23

Lower

Central

guidance

Upper

Q1 full price sales versus 2021/22 (actual)

+21.3%

+21.3%

+21.3%

Q2 - Q4 full price sales versus 2021/22

- 2.9%

+0.8%

+4.6%

Full year full price sales versus 2021/22

+2.0%

+5.0%

+8.0%

 

 

 

 

Profit before tax

£795m

£850m

£895m

Profit before tax versus 2021/22

- 3.4%

+3.3%

+8.7%

Earnings Per Share

521.3p

557.3p

586.8p

Earnings Per Share versus 2021/22

- 1.8%

+5.0%

+10.6%

For completeness, full price sales guidance against three years ago is shown below. The table demonstrates that, on a three year basis, our central guidance for sales growth for the rest of the year is 1.5% lower than that experienced in the first quarter.

Guidance for 2022/23 versus 2019/20

Lower

Central

guidance

Upper

Q1 full price sales versus 2019/20 (actual)

+19.5%

+19.5%

+19.5%

Q2 - Q4 full price sales versus 2019/20

+13.6%

+18.0%

+22.4%

Full year full price sales versus 2019/20

+15.0%

+18.4%

+21.7%

CASH FLOW, SHAREHOLDER DISTRIBUTIONS AND INVESTMENTS

In our Year End Results in March we forecast that, at our central guidance, we would generate around £220m of surplus cash (after interest, tax, capital expenditure, investments or acquisitions and ordinary dividends), which we would either (1) return to shareholders (via share buybacks or special dividends) or (2) invest in equity stakes in potential Total Platform clients. Since then, we have purchased £107.5m of shares and spent £20m acquiring minority stakes in a number of businesses, the lion's share of this investment being in JoJo Maman BéBé.

Share Buybacks

So far this year, we have purchased 1.6m shares at an average share price of £65.52, totalling £107.5m. This has reduced the number of shares in issue by 1.2% since the January 2022 year end.

SECOND QUARTER TRADING STATEMENT

Our next sales update will cover the first 26 weeks of the year to 30 July 2022 and is scheduled for Thursday 4 August 2022. 

 

Forward Looking Statements

Certain statements in this Trading Update are forward looking statements. These statements may contain the words "anticipate", "believe", "intend", "aim", "expects", "will", or words of similar meaning. By their nature, forward looking statements involve risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. As such, undue reliance should not be placed on forward looking statements. Except as required by applicable law or regulation, NEXT plc disclaims any obligation or undertaking to update these statements to reflect events occurring after the date these statements were published.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVZLFBLELLBBK
Date   Source Headline
29th Apr 20244:30 pmRNSDirector/PCA Shareholding
26th Apr 20246:12 pmRNSDirector/PDMR Shareholding
23rd Apr 20244:31 pmRNSHolding(s) in Company
12th Apr 20242:16 pmRNSAnnual Financial Report
8th Apr 20244:43 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
26th Mar 20249:50 amRNSHolding(s) in Company
22nd Mar 20242:26 pmRNSDirector/PDMR Shareholding
22nd Mar 20242:24 pmRNSDirector/PDMR Shareholding
22nd Mar 20249:15 amRNSDirector Declaration
21st Mar 20241:15 pmRNSDirector Declaration
21st Mar 202412:50 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNEXT plc Results for the Year Ended January 2024
1st Mar 20249:00 amRNSTotal Voting Rights
19th Feb 20242:27 pmRNSClosed Period Share Repurchase Programme
15th Feb 20244:58 pmRNSTransaction in Own Shares
6th Feb 20245:12 pmRNSTransaction in Own Shares
2nd Feb 20245:10 pmRNSTransaction in Own Shares
1st Feb 20245:20 pmRNSTransaction in Own Shares
1st Feb 20248:00 amRNSTotal Voting Rights
23rd Jan 20245:17 pmRNSTransaction in Own Shares
23rd Jan 20242:44 pmRNSDirector Appointment
22nd Jan 20245:41 pmRNSTransaction in Own Shares
17th Jan 20243:48 pmRNSDirector/PDMR Shareholding - Replacement
17th Jan 202412:00 pmRNSDirector Appointment
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTrading Statement
2nd Jan 20248:00 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
4th Dec 202310:45 amRNSDirector/PDMR Shareholding
4th Dec 202310:34 amRNSDirector/PDMR Shareholding
1st Dec 20238:00 amRNSTotal Voting Rights
14th Nov 20234:57 pmRNSHolding(s) in Company
13th Nov 202312:30 pmRNSAGM Update
1st Nov 20238:00 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTrading Statement
19th Oct 20234:00 pmRNSDirector/PDMR Shareholding
18th Oct 20233:00 pmRNSNew Issue and Additional Listing
13th Oct 20233:11 pmRNSAcquisition of FatFace
3rd Oct 20233:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSBoard Changes
2nd Oct 20238:30 amRNSTotal Voting Rights
25th Sep 20235:15 pmRNSDirector/PDMR Shareholding
25th Sep 20235:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20234:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSResults for the Half Year Ending July 2023
1st Sep 202312:00 pmRNSTotal Voting Rights
1st Sep 20239:30 amRNSAcquisition of Warburg Pincus’ Interest in Reiss
4th Aug 20234:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.